cro.directory
← Compare landing

iFyber, LLC vs LIDE Biotech

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/ifyber/lide-biotech

CategoryiFyber, LLCLIDE Biotech
Listed sitecrocro
SummaryPreclinical CRO providing custom method development, antimicrobial efficacy and biofilm testing, LC-MS/MS analysis, and in vitro biocompatibility studies for R&D teams. Work spans biology, chemistry, and materials science.Oncology-focused preclinical CRO with AAALAC-accredited China-based labs offering 2300+ PDX models, MiniPDX organoid assays, and multi-omics analysis for drug discovery and development.
Services
  • Microbiology Services
  • Preclinical In Vitro Studies
  • Pathology & Histology Services
  • Analytical Method Development & Validation
  • Proteomics Services
  • Biomarker Assays
  • Genomics & Sequencing Services
  • Flow Cytometry Services
  • Specialized & Large-Animal Models
  • In Vivo Efficacy Models
  • Preclinical In Vivo Studies
  • In Vitro Pharmacology
  • Preclinical In Vitro Studies
  • Genomics & Sequencing Services
  • Proteomics Services
  • Oncology Specialty Services
  • Immunology & Inflammation Services
  • Biomarker Assays
ModalitiesData not yet provided.
  • Antibody-Drug Conjugate (ADC)
  • Cell Therapy
IndicationsData not yet provided.
  • Oncology
  • Immunology
Locations
  • Headquarters, Ithaca, New York, United States
  • Headquarters, China
CertificationsData not yet provided.
  • AAALAC · Identifier: AAALAC accredited
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.